Membrane physiology as a basis for the cellular effects of Metformin in insulin resistance and diabetes

Diabetes and Metabolism

Volumn 25, Issue 2, 1999, Pages 110-127

  Wiernsperger, N F ^a  

^a Groupe Lipha   (France)

Author keywords

Diabetes; Glucose transporters; Insulin receptor; Insulin resistance; Membrane fluidity; Metformin; Tyrosine kinase

Indexed keywords

GLUCOSE TRANSPORTER; GLYCOGEN SYNTHASE; INSULIN; INSULIN RECEPTOR; METFORMIN; PROTEIN TYROSINE KINASE;

CELL LEVEL; CELL MEMBRANE FLUIDITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG HALF LIFE; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN CONFORMATION; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

ANIMALS; BLOOD GLUCOSE; CELL MEMBRANE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; METFORMIN; RECEPTOR, INSULIN;

EID: 0032789150     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (174)

1. Bailey CJ. Biguanides in the treatment of type II diabetes. Curr Opin Endocrinol and Diabetes, 1995, 2, 348-354.
2. Hermann LS. Clinical pharmacology of biguanides. In: Kuhlmann J, Puls W eds. "Handbook of experimental pharmacology." Springer Verlag, 1996, 119, 374-407.
3. Wiernsperger N. Preclinical pharmacology of biguanides. In: Kuhlmann J, Puls W eds. "Handbook of experimental pharmacology." Springer Verlag, 1996, 305-358.
4. Wiernsperger N, Rapin JR. Metformin-insulin interactions: from organ to cell. Diabetes/Metabolism Reviews, 1995, 11, S3-S12.
5. Cusi K, DeFronzo RA. Metformin: a review of its metabolic effects. Diabetes Reviews, 1998, 6, 89-131.
6. Wiernsperger N, Bailey CJ. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs (in press).
7. Wilcock C, Bailey CJ. Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica, 1994, 24, 49-57.
8. Cuber JC, Bosshard A, Vidal H, Vega F, Wiernsperger N, Rapin JR. Metabolic and drug distribution studies do not support direct inhibitory effects of metformin on intestinal glucose absorption. Diabetes & Metabolism, 1994, 20, 532-539.
9. Beckmann R. Resorption, Verteilung im Organismus und Ausscheidung von Metformin. Diabetologia. 1969, 5, 318-324.
10. Wollen N, Bailey CJ. Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin. Biochem Pharmacol, 1988, 37, 4353-4358.
11. Kozka IJ, Holman DH. Metformin blocks downregulation of cell surface GLUT4 caused by chronic insulin treatment of rat adipocytes. Diabetes, 1993, 42, 1159-1165.
12. Matthaei S, Hamann A, Klein HH et al. Evidence that metformin increases insulin-stimulated glucose transport by potentiating insulin-inducer translocation of glucose transporters from an intracellular pool to the cell surface in rat adipocytes. Horm Metab Res, 1992, 26 (Suppl.) 34-41.
13. Sasson S, Gorowits N, Joost HG, King GL, Cerasi E, Kaiser N. Regulation by metformin of the hexose transport system in vascular endothelial and smooth muscle cells. Br J Pharmacol, 1996, 117, 1318-1324.
14. Lalau JD, Race JM, Brinquin L. Lactic acidosis in metformin therapy. Relationship between plasma metformin concentration and renal function. Diabetes Care, 1998, 21, 1366-1367.
15. Klip A, Leiter LA. Cellular mechanism of action of metformin. Diabetes Care, 1990, 13, 696-704.
16. Cartee GD, Douen AG, Ramlal T, Klip A, Holloszy JO. Stimulation of glucose transport in skeletal muscle by hypoxia. J Appl Physiol, 1991, 70, 1593-1600.
17. Golay A, Guillet Dauphine N, Fendel E, Juge C, Assal JP. The insulin sparing effect of metformin in nsulin-treated diabetic patients. Diabetes Metab Rev, 1995, 11 (Suppl. 1) S63-S67.
18. Sterne J. Mécanisme d'action des biguanides antidiabétiques. Gaz Med, 1968, 4, 793-807.
19. Bailey CJ, Mynett KJ. Insulin requirement for the antihyperglycaemic effect of metformin. Br J Pharmacol, 1994, 111, 793-796.
20. Fischer Y, Thomas J, Rösen P, Kammermeier H. Action of metformin on glucose transport and glucose transporter GLUT1 and GLUT4 in heart muscle cells from healthy and diabetic rats. Endocrinology, 1995, 136, 412-420.
21. Gould MK, Chaudry IH. The action of insulin on glucose uptake by isolated rat soleus muscle. Dissociation of a priming effect of insulin from its stimulatory effect. Biochim Biophys Acta, 1970, 215, 258-263.
22. Barzilai N, Simonson D. Mechanism of metformin action in NIDDM. [Abstract]. Diabetes, 1988, 37, Suppl. 1, 244.
23. DeFronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. Clin Endocrinol Metab, 1991, 73, 1294-1301.
24. Perriello G, Misericordia P, Volpi E et al. Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppresssion of lipid oxidation and hepatic glucose production. Diabetes, 1994, 43, 920-928.
25. Sarabia V, Lam L, Burdett E, Leiter LA, Klip A. Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J Clin Invest, 1992, 90, 1386-1395.
26. Sargeant R, Mitsumoto Y, Sarabia V, Shillabeer G, Klip A. Hormonal regulation of glucose transporters in muscle cells in culture. J Endocrinol Invest, 1993, 16, 147-162.
27. Yoa RG, Rapin JR, Wiernsperger N, Martinand A, Belleville I. Demonstration of defective glucose uptake and storage in erythrocytes from non-insulin-dependent diabetic patients and effects of metformin. Clin Exp Pharmacol Physiol, 1993, 20, 563-567.
28. Purrello F, Gullo D, Brunetti A et al. Direct effects of biguanides on glucose utilization in vitro. Metabolism, 1987, 36, 774-776.
29. Kelley DE, Mandarino LJ. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest, 1990, 86, 1999-2007.
30. Revers RR, Fink R, Griffin J, Olefsky JM, Kolterman OG. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes. J Clin Invest, 1984, 73, 664-672.
31. Del Prato S, Matsuda M, Simonson DC et al. Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia, 1997, 40, 687-697.
32. Raman P, Foster SE, Stokes MC Judd RL. Effect of metformin on lactate and glucagon stimulated gluconeogenesis in isolated rat hepatocytes: impact of glucose and fasting. FASEB J, 1997, 11, A155.
33. Yu B, Pugazhenthi S, Khandelwal RL. Effects of metformin on glucose and glucagon regulated gluconeogenesis in cultured normal and diabetic hepatocytes. Biochem Pharmacol, 1994, 48, 949-954.
34. Anfosso F, Chomiki N, Alessi MC, Vague P, Juhan Vague I. Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line hep G2. Metformin inhibits the stimulating effect of insulin. J Clin Invest, 1993, 91, 2185-2193.
35. Alengrin F, Grossi G, Canivet B, Dolai-Kitabgi J. Inhibitory effects of metformin on insulin and glucagon action in rat hepatocytes involve post-receptor alterations. Diabète et Metabolisme, 1987, 13, 591-597.
36. Hundal HS, Ramlal T, Reyes R, Leiter LA, Klip A. Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology, 1992, 131, 1165-1173.
37. Pears JS, Jung RT, Burchell A. Contrasting effects of metformin on glucose-6-phosphatase from fed and diabetic livers. Diabetic Med, 1990, 7, Suppl 2, 12A.
38. Meuillet E, Wiernsperger N, Hubert P, Cremel G. Biguanide effects on insulin signaling. Ann N Y Acad Sci, 1997, 827, 546-549.
39. Galuska D, Nolte LA, Zierath JR, Wallberg-Henriksson H. Effect of metformin on insulin-stimulated glucose transport in isolated skeletal muscle obtained from patients with NIDDM. Diabetologia, 1994, 37, 826-832.
40. Signore A, Fiore V, Chianelli M et al. Effect of metformin on liver insulin metabolism and regional blood flow. Diabetes Metab Rev, 1995, 11 (Suppl. 1), S13-S21.
41. Eriksson JG, Widen EI, Saloranta C. Metformin improved insulin sensitivity in insulin resistant normoglycemic relatives of patients with non-insulin-dependent diabetes mellitus. [Abstract]. Diabetes, 1990, 39 (Suppl. 1), 109A.
42. Faure P, Rossini E, Wiernsperger N, Richard MJ, Favier A, Halimi S. An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. Diabetes, 1999, 48, 353-357.
43. Minassian C, Tarpin S, Mithieux G. Role of glucose-6 phosphatase, glucokinase, and glucose-6 phosphate in liver insulin resistance and its correction by metformin. Biochem Pharmacol, 1998, 55, 1213-1219.
44. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clorniphene-induced ovulation in the polysystic ovary syndrome. NEJM, 1998, 338, 1876-1880.
45. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. NEJM, 1995, 333, 550-554.
46. Radziuk J, Zhang Z, Wiernsperger N, Pye S. Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver. Diabetes, 1997, 46, 1406-1413.
47. Komori T, Hotta N, Kobayashi M, Sakakibara F, Koh N, Sakamoto N, Biguanides may produce hypoglycemic action in isolated rat hepatocytes through their effects on L-alanine transport. Diabetes Res Clin Pract, 1993, 22, 11-17.
48. Argaud D, Roth H, Wiernsperger N, Leverve XM. Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes. Eur J Biochem, 1993, 213, 1341-1348.
49. Ferlito S, Del Campo F, Di Vincenzo S et al. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin-dependent diabetics. Farmaco, 1983, 38, 248-254.
50. Gawler DJ, Milligan G, Houslay MD. Treatment of streptozotocin-diabetic rats with metformin restores the ability of insulin to inhibit adenylate cyclase activity and demonstrates that insulin does not exert this action through the inhibitory guanine nucleotide regulatory protein Gi. Biochem J, 1988, 249, 537-542.
51. Gawler DJ, Wilson A, Houslay MD. Metformin treatment of lean and obese Zucker rats modulates the ability of glucagon and insulin to regulate hepatocyte adenylate cyclase activity. Endocrinology, 1989, 122, 207-212.
52. Ubl JJ, Chen S, Stucki JW. Anti-diabetic biguanides inhibit hormone-induced intracellular Ca2 + concentration oscillations in rat hepatocytes. Biochem J, 1994, 304, 561-567.
53. Bouix O, Lautier C, Macari F, Chavanieu A, Grigorescu F. La metformin potentialise l'activité phosphatidylinositol 3-kinase stimulée par l'insuline par un recrutement de l'IRS-2 (insulin-receptor substrate-2) dans le foie de rat. Ann Endocrinol, 1997, 58, 112.
54. Detaille D, Devos P. Wiernsperger N. Potentiating effect of metformin on insulin-induced glycogen uptake and glycogen metabolism within xenopus oocytes. Diabetologia, 1998, 41, 2-8.
55. Rapin JR, Lespinasse C, Yoa RG, Wiernsperger N. Erythrocyte glucose consumption in insulin-dependent diabetes: effect of metformin in vitro. Diabete Metab, 1991, 17, 164-167.
56. Kanigür-Sultuybek G, Hatemi H, Ģven M, Ulutin T, Tezcan V, Ulutin ON. The effect of metformin and gliclazide on platelets and red blood cell glucose transport mechanisms in impaired glucose tolerance and type II diabetic patients with vasculopathy. Thromb Haemorrh Disorders, 1993, 7/1, 17-21.
57. Estrada DE, Elliott E, Zinman B, Poon I, Liu Z, Klip A, Daneman D. Regulation of glucose transport and expression of GLUT3 transporters in human circulating mononuclear cells: studies in cells from insulin-dependent diabetic and nondiabetic individuals. Metabolism, 1994, 43, 91-598.
58. Bastard JP, Rossini E, Jardel C, Halimi S, Hainque B. Tissue-specific regulation of GLUT4 expression in fructose-induced insulin resistance in the rat. Diabetologia, 1996, 39 (Suppl. 1), A172.
59. Handberg A, Kayser L, Hoyer PE, Voldstedlund M, Hansen HP, Vinten J. Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats. Diabetologia, 1993, 36, 481-486.
60. Matthaei S, Haman A, Klein HH et al. Association of metformin's effect to increase insulin-stimulated glucose transport with potentiation of insulin-induced translocation of glucose transporters from intracellular pool to plasma membrane in rat adipocytes. Diabetes, 1991, 40, 850-857.
61. Rouru J, Koulu M, Peltonen J et al. Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats. Br J Pharmacol, 1995, 115, 1182-1187.
62. Cortes P, Riser BL, Asano K, Rodriguez-Barbero A, Narins RG, Yee J. Effects of oral antihyperglycemic agents on extracellular matrix synthesis by mesangial cells. Kidney Int, 1998, 54, 1985-1998.
63. Thomas CR, Turner SL, Jefferson WH, Bailey CJ. Prevention of dexamethasone-induced insulin resistance by metformin. Biochem Pharmacol, 1998, 56, 1145-1150.
64. Lenzen S, Lortz S, Tiedge M. Effects of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats. Biochem Pharmacol, 1996, 51, 893-896.
65. Hamann A, Benecke H, Greten H, Matthaei S. Metformin increases glucose transporter protein and gene expresssion in human fibroblasts. Biochem Biophys Res Comm, 1993, 196, 382-387.
66. Wang W, Hansen PA, Marshall BA, Holloszy JO, Mueckler M. Insulin unmasks a code-terminal GLUT 4 epitope and increases GT across T-tubules in skeletal muscle. J Cell Biol, 1996, 135, 415-430.
67. Baly DL, Horuk R. Dissociation of insulin-stimulated glucose transport from the translocation of glucose carriers in rat adipose cells. J Biol Chem, 1987, 262, 21-24.
68. Czech MP, Clancy BM, Pessino A, Woon CW, Harrison SA. Complex regulation of simple sugar transport in insulin-responsive cells. TIBS, 1992, 17, 197-201.
69. Czech MP. Molecular actions of insulin on glucose transport. Annu Rev Nutr, 1995, 15, 441-471.
70. Matthaei S, Reibold JP, Hamann A et al. In vivo metformin treatment ameliorates insulin resistance: evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes. Endocrinology, 1993, 133, 304-311.
71. Napoli R, Hirshman MF, Horton ES. Mechanisms and time course of impaired skeletal muscle glucose transport activity in streptozocin diabetic rats. J Clin Invest, 1995, 96, 427-437.
72. Coderre L, Vallega GA, Pilch PF, Chipkin SR. In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution. Am J Physiol, 1996, 271, E643-E648.
73. Davidson MB, Bouch C, Venkatesan N. Impaired glucose transport in skeletal muscle but normal GLUT 4 content and translocation in glucose-infused rats. Diabetes, 1994, 43 (SI), 127.
74. Rosholt MN, King PA, Horton ES. High-fat diet reduces glucose transporter responses to both insulin and exercise. Am J Physiol, 1994, 266, R95-R101.
75. Rizk NM, Meier DA, Krakower GR, Kissebah AH. Mechanisms of insulin-resistant glucose utilization in rat skeletal muscle. Mol Gen Metab, 1998, 63, 126-133.
76. Ong KC, Khoo HE. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transporter translocation. Biochem Pharmacol, 1996, 51, 423-429.
77. Detaille D, Devos P, Wiernsperger N. Respective molecular effects of insulin and metformin on glucose uptake using the Xenopus oocyte model as expression system. Diabetologia, 1988, 41 (Suppl.1), 707.
78. Komori T, Nakamura J, Hamada Y, Koh N, Hotta N. Effects of glucosamine, metformin, and JTT-501 on glycogen synthesis in cultured myotubes from human NIDDM subject. [Abstract]. Diabetes, 1998, 47 (Suppl. 1).
79. Lord JM, Puar JA, Atkins TW, Bailey CJ. Postreceptor effect of metformin on insulin action in mice. J Pharm Pharmacol, 1985, 37, 821-823.
80. Reddi AS, Jyothirmayi GN. Effect of chronic metformin treatment on hepatic and muscle glycogen metabolism in KK mice. Biochem Med and Metab Biol, 1992, 47, 124-132.
81. Rossetti L, DeFronzo RA, Gherzi R et al. Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. Metabolism, 1990, 39, 425-435.
82. Damsbo P, Handberg A, Beck-Nielsen H. Reversibility of the defect in glycogen synthase activity in skeletal muscle from obese NIDD's treated with diet and metformin. [Abstract]. Diabetes, 1990, 39, Suppl.1, 1070.
83. Romero MF, Kanai Y, Gunshin H, Hediger MA. Expression cloning using Xenopus laevis oocytes. Methods in Enzymology, 1998, 296, 17-52.
84. Janicot M, Lane MD. Activation of glucose uptake by insulin and insulin-like growth factor 1 in Xenopus oocytes. Proc Natl Acad Sci, 1989, 86, 2642-2646.
85. Grigorescu F, Baccara MT, Rouard M, Renard E. Insulin and IGF-I signaling in oocyte maturation. Horm Res, 1994, 42, 55-61.
86. Holle A, Mangels W, Dreyer M, Kühnau J, Rüdiger HW. Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes. NEJM, 1981, 305, 563-566.
87. Kanigür-Sultuybek G, Güven M, Onaran I, Tezcan V, Cenani A, Hatemi H. The effect of metformin on insulin receptors and lipid peroxidation in alloxan and streptozotocin induced diabetes. J Basic Clinical Physiol Pharmacol, 1995, 6, 271-280.
88. Fantus IG, Brosseau R. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo. J Clin Endocrinol Metab, 1986, 63, 898-905.
89. Wu MS, Johnston P, Sheu WHH et al. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients. Diabetes Care, 1990, 13, 1-8.
90. Myers MG, White MF. Insulin signal transduction and the IRS proteins. Annu Rev Pharmacol Toxicol, 1996, 36, 615-58.
91. Zaibi MS, Padieu P, Chessebeuf-Padieu M, El Baraka M, Wiernsperger N, Rapin JR. Metformin induces an agonist-specific increase in albumin production by primary cultured rat hepatocytes. Biochem Pharmacol, 1995, 50, 6, 775-780.
92. Grigorescu F, Laurent A, Chavanieu A, Capony JP. Cellular mechanism of metformin action. Diabete Metab, 1991, 17, 146-149.
93. Khan NA, Wiernsperger N, Quemener V, Moulinoux JP. Internalization of metformin is necessary for its action on potentiating the insulin-induced Xenopus laevis oocyte maturation. J Endocrinol, 1994, 142, 245-250.
94. Santos RF, Nomizo R, Wajhenberg BL, Reaven GM, Azhar S. Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes. Diabetes & Metabolism, 1995, 21, 274-280.
95. Santos RF, Nomizo R, Bopsco A, Wajchenberg BL, Reaven GM, Azhar S. Effect of metformin on insulin stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance. Diabetes & Metabolism, 1997, 23, 143-148.
96. Melin B, Cherqui G, Blivet MJ et al. Dual effect of metformin in cultured rat hepatocytes: potentiation of insulin action and prevention of insulin-induced resistance. Metabolism, 1990, 39, 1089-1095.
97. Stith BJ, Goalstone ML, Espinoza R, Mossel C, Roberts D, Wiernsperger N. The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4, 5-trisphosphate mass in Xenopus oocytes. Endocrinology, 1996, 137, 2990-2999.
98. Stith BJ, Woronoff K, Wiernsperger N. Stimulation of the intracellular portion of the human insulin receptor by the antidiabetic drug metformin. Biochem Pharmacol, 1998, 55, 533-536.
99. Ohan N, Bayaa M, Kumar P, Zhu L, Liu XJ. A novel insulin receptor substrate protein, xIRS-u, potentiates insulin signaling: functional importance of its pleckstrin homology domain. Mol Endocrinol, 1998, 12, 1086-1098.
100. Detaille D, Devos P, Wiernsperger N. Identification of the mechanisms involved in the potentiating effects of metformin on insulin-induced glycogen synthase activity in xenopus eggs. Diabetologia, 1997, 40 (Suppl. 1), 603.
101. Reusch JEB, Sussman KE, Draznin B. Inverse relationship between GLUT-4 phosphorylation and its intrinsic activity. J Biol Chem, 1993, 268, 3348-3351.
102. Begum N, Leitner W, Reusch JEB, Sussmann KE, Draznin B. GLUT-4 phosphorylation and intrinsic activity. Mechanism of Ca ++ -induced inhibition of INS-stimulated GT. J Biol Chem, 1993, 268, 3352-3356.
103. Dominguez LJ, Davidoff AJ, Srinivas PR, Standley PR, Walsh MF, Sowers JR. Effects of metformin on tyrosine kinase activity, glucose transport, and intracellular calcium in rat vascular smooth muscle. Endocrinology, 1996, 137, 113-121.
104. Jacobs DB, Hayes GR, Truglia JA, Lockwood DH. Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes. Diabetologia, 1986, 29, 798-801.
105. Turnbow MA, Smith LK, Garner CW. The oxazolidinedione CP-92, 768-2 partially protects IRS-1 from dexamethasone down-regulation in 3T3-L1 adipocytes. Endocrinology, 1995, 136, 1450-1458.
106. Worm D, Handberg A, Hoppe E, Vinten J, Beck-Nielsen H. Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence. Diabetologia, 1996, 39, 142-148.
107. Nolan JJ, Freidenberg G, Henry R, Reichart D, Olefsky JM. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. Clin Endocrinol Metab, 1994, 78, 471-477.
108. LeMarchand-Brustel Y, Gremeaux T et al. Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice. Nature, 1985, 315, 676-679.
109. Ellis L, Clauser E, Morgan DO et al. Replacement insulin receptor tyrosine residues 1162 and 1163 compromise insulin-stimulated kinase activity and uptake of 2-deoxylglucose. Cell, 1986, 45, 721-732.
110. Nakamura SY, Thirone ACP, Carvalho CRO, Janeri L, Saad MJA. Effect of metformin on early steps of insulin signal transduction in liver and muscle of aging rats. [Abstract]. Diabetes, 1998, 47 (Suppl. 1), 1148.
111. Rother KI, Caruso M, Beguinot F, Formisano P, Accili D. Metabolic and growth promoting actions of insulin in hepatocytes require tyrosine phosphorylation. Diabetes, 1998, 47 (Suppl. 1), 133.
112. Kayali AG, Eichhorn J, Haruta T et al. Association of the insulin receptor with phospholipase C-? in metabolic signaling by insulin. J Biol Chem, 1998, 273, 13808-13818.
113. Stralfors P. Insulin second messengers. BioEssays, 1997, 19, 327-335.
114. Wasner HK, Salgue U, Psarakis E, Niktopoulos A. Insulin resistance, a result of reduced synthesis of prostaglandylisositol cyclic phosphate, a mediator of insulin action. Acta Diabetol, 1997, 34, 257-264.
115. Walkenbach RJ, Hazen R, Larner J. Reversible inhibition of cyclic amp-dependent protein kinase by insulin. Mol Cell Biochem, 1978, 19, 31-41.
116. Obermaier-Kusser B, Muhlbacher C, Mushack J, Rattenhuber E, Fehlmann M, Huring HU. Regulation of glucose carrier activity by AlC13 and phospholipase C in fat-cells. Biochem J, 1988, 256, 515-520.
117. Schäfer G. On the mechanism of action of hypoglycemia producing biguanides: a reevaluation and molecular theory. Biochem Pharmacol, 1976, 25, 2005-2014.
118. Blecher M. Phospholipase C and mechanisms of action of insulin and cortisol on glucose entry into free adipose cells. Biochem Biophys Res Comm, 1965, 21, 202-209.
119. Freisleben HJ, Furstenberger HJ, Deisinger S, Freisleben KB, Wiernsperger N, Zimmer G. Interaction of glucose and metformin with isolated red cell membrane. Arzneim-Forsch Drug Res, 1996, 46, 773-778.
120. Jans DA. The mobile receptor hypothesis revisited: a mechanistic role for hormone receptor lateral mobility in signal transduction. Biochim Biophys Acta, 1992, 1113, 271-276.
121. Gustavsson J, Parpar S, Stralfors P. Insulin-stimulated glucose uptake involves the transition of glucose transporters to a caveolae-rich fraction within the plasma membrane: implications for type II diabetes. Mol Med, 1996, 2, 367-372.
122. Kinnunen PKJ. On the principles of functional ordering in biological membranes. Chemistry and Physics of Lipids, 1991, 57, 375-399.
123. Pilch PF, Thompson PA, Czech MP. Coordinate modulation of D-glucose transport activity and bilayer fluidity in plasma membranes derived from control and insulin-treated adipocytes. Proc Natl Acad Sci USA, 1980, 77, 915-918.
124. Kimelberg HK. The influence of membrane fluidity on the activity of membrane-bound enzymes. In: Poste G, Nicolson GL, eds. "Dynamic aspects of cell surface organization". Elsevier/North-Holland Biomedical Press, 1977, 205-293.
125. Berdanier CD. Role of membrane lipids in metabolic regulation. Nutrition Rev, 1988, 46, 145-149.
126. Carruthers A, Melchior DL. How bilayer lipids affect membrane protein activity. TIBS, 1996, 11, 331-335.
127. Read BD, McElhaney RN. Influence of membrane lipid fluidity on glucose and undine facilitated diffusion in human erythrocytes. Biochim Biophys Acta, 1976, 419, 331-341.
128. Whitesell RR, Regen DM, Beth AH, Pelletier DK, Abumrad NA. Activation energy of the slowest step in the glucose carrier cycle: break at 23°C and correlation with membrane lipid fluidity. Biochemistry, 1989, 28, 5618-5625.
129. Czech MP. Insulin action and the regulation of hexose transport. Diabetes, 1980, 29, 399-409.
130. Yuli I, Wilbrandt W, Shinitzky M. Glucose transport through cell membranes of modified lipid fluidity. Biochemistry, 1981, 20, 4250-4256.
131. Trowbridge M, Sussman A, Ferguson L et al. Mechanisms of the fasting-induced dissociation of insulin binding from its action in isolated rat hepatocytes. Mol Cell Biochem, 1984, 62, 25-36.
132. Zick Y. The insulin receptor: structure and function. Crit Rev Biochem Mol Biol, 1989, 24, 217-269.
133. Dutta-Roy AK, Ray TK, Sinha AK. Control of erythrocyte membrane microviscosity by insulin. Biochim Biophys Acta, 1985, 816, 187-190.
134. Hyslop PA, Kuhn CE, Sauerheber RD. Insulin stimulation of adipocyte membrane glucose transport. A graded biologic response insensitive to bilayer lipid disordering. Biochem Pharmacol, 1987, 36, 2305-2310.
135. McMillan DE. Insulin, diabetes, and the cell membrane: an hypothe-sis. Diabetologia, 1983, 24, 308-310.
136. Candiloros H, Zeghari N, Ziegler O, Donner M, Drouin P. Hyperinsulinemia is related to erythrocyte phospholipid composition and membrane fluidity changes in obese nondiabetic women. J Clin Endocrinol and Metabolism, 1996, 81, 2912-2918.
137. Farias RN. Membrane cooperative enzymes as a tool for the investigation of membrane structure and related phenomena. Adv Lipid Res, 1980, 17, 251-282.
138. Luly P, Baldini P, Incerpi S, Tria E. Insulin effect in vitro on human erythrocyte plasma membrane. Experientia, 1981, 37, 431-433.
139. Stuschke M, Bojar H. Insulin effect on translational diffusion of lipids and proteins in the plasma membrane of isolated rat hepatocytes. Biochim Biophys Acta, 1985, 845, 436-444.
140. McCallum CD, Epand RM. Insulin receptor autophosphorylation and signaling is altered by modulaton of membrane physical properties. Biochemistry, 1995, 34, 1815-1824.
141. Cortizo AM, Paladini A, Diaz GB, Garcia ME, Gagliardino JJ. Changes induced by glucose in the plasma membrane properties of pancreatic islets. Mol Cell Endocrinol, 1990, 71, 49-54.
142. Freisleben HJ, Ruckert S, Wiernsperger N, Zimmer G. The effects of glucose, insulin and metformin on the order parameters of isolated red cell membranes. Biochem Pharmacol, 1992, 43, 1185-1194.
143. Nassar K, Cheng S, Levy D. The effect of diabetes on hepatocyte plasma membrane fluidity and concanavalin A-induced agglutination. Exp Cell Res, 1981, 132, 99-104.
144. Watala C. In vitro glycation of red blood cell proteins: high levels of glucose lower lipid fluidity of erythrocyte membranes. Exp. Pathol, 1988, 33, 233-238.
145. Caimi G, Presti RL, Montana M et al. Membrane fluidity, membrane lipid pattern, and cytosolic Ca2+ content in platelets from a group of type II diabetic patients with macrovascular complications. Diabetes Care, 1995, 18, 60-63.
146. Muller S, Denet S, Candiloros H et al. Action of metformin on erythrocyte membrane fluidity in vitro and in vivo. Eur J Pharmacol, 1997, 337, 103-110.
147. Kamada T, Otsuji S. Lower levels of erythrocyte membrane fluidity in diabetic patients. Diabetes, 1983, 32, 585-591.
148. Winocour PD, Bryszewska M, Watala C et al. Reduced membrane fluidity in platelets from diabetic patients. Diabetes, 1990, 39, 241-244.
149. Kordowiak AM, Wojas J, Subczynski WK. Fluidity of rat liver Golgi membranes in streptozotocin diabetes. A spin label study. Biochim Biophys Acta, 1990, 1022, 296-302.
150. Schäfer G. Biguanides, A review of history, pharmacodynamics and therapy. Diabète et Métabolisme, 1983, 9, 148-163.
151. Mori K, Nakamura J, Koh N et al. Increased alanine uptake and lipid synthesis from alanine in isolated hepatocytes of Wistar-Kyoto fatty rats: an inhibitory effect of biguanides. Can J Physiol Pharmacol, 1997, 75, 179-184.
152. Colantuoni A, Bertuglia S, Donato L. Effects of metformin on microvascular permeability in diabetic Syrian hamsters. Diabete Metab, 1988, 14, 549-553.
153. Bouskela E, Wiernsperger N. Effects of metformin on hemorrhagic shock, blood volume, and ischemia/reperfusion on nondiabetic hamsters. J Vasc Med Biol, 1993, 4, 41-46.
154. Bertuglia S, Colantuoni A, Donato L. Effects of metformin on microcirculation during hemorrhagic shock. In: Strano A, Novo S eds. Proc XV World Congress IUA, Rome. Elsevier Science Publishers, Excerpta Medica, 1989, 1189-1194.
155. Wilcock C, Wyre ND, Bailey CJ. Subcellular distribution of metformin in rat liver. J Pharm Pharmacol, 1991, 43, 442-444.
156. Khan NA, Wiernsperger N, Quemener V, Havouis R, Moulinoux JP. Characterization of metformin transport system in NIH 3T3 cells. J Cell Physiol, 1992, 152, 310-316.
157. Sung LA, Lo WK. Immunodetection of membrane skeletal protein 4.2 in bovine and chicken eye lenses and erythrocytes. Curr Eye Res, 1997, 16, 1127-1133.
158. Jones MN, Nickson JK. Monosaccharide transport proteins of the human erythrocyte membrane. Biochim Biophys Acta, 1981, 650, 1-20.
159. Abbott RE, Schachter D. Topography and sulfhydryl groups of the human erythrocyte glucose transport mechanism. Mol Cell Biochem, 1988, 82, 85-90.
160. Gallacher SJ, O'Donnell M, Reglinski J, Smith WE, Wilson R, McCuish AC. Oxidative stress in diabetes. Effect on erythrocyte membrane sulfhydryl populations. Diabet.Med, 1993, 10 (Suppl. 1), 57-62.
161. May JM. Interaction of the permeant maleimide derivative of cysteine with the erythrocyte glucose carrier. Differential labelling of an exofacial carrier thiol group and its role in the transport mechanism. Biochem J, 1989, 263, 875-881.
162. Deuticke B. The role of membrane sulfhydryls in passive, mediated transport processes and for the barrier function of the erythrocyte membrane. Membr Biochem, 1986, 6, 309-326.
163. Li SL, Miyata Y, Yahara I, Fujita-Yamaguchi Y. Insulin-induced circular membrane ruffling on rat 1 cells expressing a high number of human insulin receptors: circular ruffles caused by rapid actin reorganization exhibit high density of insulin receptors and phosphotyrosines. Exp Cell Res, 1993, 205, 353-360.
164. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG, Ishikawa Y. Caveolin is an activator of insulin receptor signaling. Biol Chem, 1998, 273, 26962-26968.
165. Lisanti MP, Scherer PE, Tang Z, Sargiacomo M. Caveolae, caveolin and caveiollin-rich membrane domains: a signalling hypothesis. Trends in cell biology, 1994, FORUM, 231-235.
166. Tsakiridis T, Vranic M, Klip A. Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J Biol Chem, 1994, 269, 29934-29942.
167. Sargiacomo M, Sudol M, Tang ZL, Lisanti MP. Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins from caveolin-rich insoluble complex in MDCK cells. J Cell Biol, 1993, 122, 789-807.
168. Biener Y, Feinstein R, Mayak M, Kaburagi Y, Kadowaki T, Zick Y. Annexin II is a novel player in insulin signal transduction. J Biol Chem, 1996, 271, 29489-29496.
169. Burgoyne RD, Geisow MJ. The annexin family of calcium-binding proteins. Cell calcium, 1989, 10, 1-10.
170. Kaetzel MA, Dedman JR. Annexins: Novel Ca 2 + -dependent regulators of membrane function. NIPS, 1995, 10, 171-176.
171. Fujimoto T, Nakade S, Miyawaki A, Mikoshiba K, Ogawa K. Localization of inositol 1,4, 5-trisphosphate receptor-like protein in plasmalemmal caveolae. J Cell Biol, 1992, 119, 1507-1514.
172. Cigolini M, Bosello O, Zancanaro C, Orlandi PG, Fezzi O, Smith U. Influence of metformin on metabolic effect of insulin in human adipose tissue in vitro. Diabete Metab, 1984, 10, 311-315.
173. Albert SG. The effect of insulin on glucose transport in rabbit erythrocytes and reticulocytes. Life Sci, 1982, 31, 265-271.
174. Guarner V, Alvarez-Buylla R. Erythrocytes and glucose homeostasis in rats. Diabetes, 1989, 3, 410-415.